March 10, 2023
House Energy and Commerce Subcommittee on Health advances five bills addressing health care, controlled substances, and suicide prevention
On March 8, the House Energy & Commerce Subcommittee on Health advanced five bills on health care, the new suicide prevention lifeline, and controlled substances. The bills now go to the full House Energy and Commerce Committee.
Three of the bills advanced aim to address the fentanyl crisis by adding new requirements for drug manufacturers, distributors and the Drug Enforcement Agency regarding suspicious orders of controlled substances; classifying fentanyl-related substances as a schedule I drug; and amending the Public Health Services Act to expand Title 42 to allow the Health and Human Services (HHS) Secretary to suspend persons or imports related to certain controlled substances from certain countries. The subcommittee also advanced a bill to ban the use of quality-adjusted life years (QALYs) from being used in determining coverage, reimbursement, or incentive program thresholds for all federal health care programs, as well as a bill to protect the 988 suicide hotline from cyber threats.
More information is available here.
Additional information is also available in the attached Tax Alert.
Subcommittee on Health advanced bills